Saturday, November 6, 2021
- 8:30AM-10:30AM
-
Abstract Number: 0434
Protein Profiling in Pre-dating Samples Separate MPO-ANCA Vasculitis from PR3-ANCA Vasculitis
Vasculitis – ANCA-Associated Poster (0414–0436)- 8:30AM-10:30AM
-
Abstract Number: 0241
Psoriasis Rate Is Increased by the Exposure to TNF Inhibition in Children with JIA
Pediatric Rheumatology – Clinical Poster I: JIA (0241–0265)- 8:30AM-10:30AM
-
Abstract Number: 0046
Psoriatic Arthritis Skin Is Transcriptionally Different to Psoriasis Skin and Enriched in Immunoglobulin Transcripts
Spondyloarthritis Including PsA – Basic Science Poster (0046–0068)- 8:30AM-10:30AM
-
Abstract Number: 0267
Psychosocial and Health Measures in Systemic Lupus Erythematosus: Before and During the COVID-19 Pandemic in the Georgian’s Organized Against Lupus Cohort
Psychology/Social Sciences Poster (0266–0267)- 8:30AM-10:30AM
-
Abstract Number: 0276
Pulse Pressure as a Predictor of Carotid Plaque in Rheumatoid Arthritis Patients
RA – Diagnosis, Manifestations, & Outcomes Poster I: Cardiovascular Pulmonary Disease (0268–0295)- 8:30AM-10:30AM
-
Abstract Number: 0213
Quantitative Assessment of Volumetric Change in Hip Effusion Using Artificial Intelligence in Patients with Osteoarthritis of the Hip
Osteoarthritis – Clinical Poster I (0210–0224)- 8:30AM-10:30AM
-
Abstract Number: 0272
RA Disease Activity Is an Independent Predictor of Left Ventricular Mass Changes in an RA Cohort Without Cardiovascular Disease
RA – Diagnosis, Manifestations, & Outcomes Poster I: Cardiovascular Pulmonary Disease (0268–0295)- 8:30AM-10:30AM
-
Abstract Number: 0329
Racial and Ethnic Disparities in Risk of End-Organ Disease Following SLE Diagnosis in a Multi-Ethnic Cohort
SLE – Diagnosis, Manifestations, & Outcomes Poster I: Diagnosis (0323–0356)- 8:30AM-10:30AM
-
Abstract Number: 0342
RAIL Distinguishes Responder and Non-Responder in Pediatric Lupus Nephritis
SLE – Diagnosis, Manifestations, & Outcomes Poster I: Diagnosis (0323–0356)- 8:30AM-10:30AM
-
Abstract Number: 0199
Rapid Improvement in Cystoid Macular Edema with High Dose Intravenous Methylprednisolone in Non-Infectious Uveitis of Different Immune Mediated Inflammatory Diseases
Miscellaneous Rheumatic & Inflammatory Diseases Poster I (0183–0209)- 8:30AM-10:30AM
-
Abstract Number: 0337
Rarity of Pneumocystis Jirovecii Pneumonia in Patients with Systemic Lupus Erythematosus Using a Real-world, Electronic Health Record
SLE – Diagnosis, Manifestations, & Outcomes Poster I: Diagnosis (0323–0356)- 8:30AM-10:30AM
-
Abstract Number: 0113
Reactogenicity of the SARS-CoV-2 Vaccines Associates with Immunogenicity in Patients with Autoimmune and Inflammatory Disease
Epidemiology & Public Health Poster I: COVID-19 & Vaccination (0084–0117)- 8:30AM-10:30AM
-
Abstract Number: 0129
Real-World Flare Rates and Progression by Treatment Settings Among the Commercially-Insured Systemic Lupus Erythematosus Population in the U.S